Oracle is rated a "Buy" after a 40% pullback, with the current valuation reflecting key risks. ORCL's $523 billion RPO is increasingly diversified, with new contracts from Meta and Nvidia reducing ...

Oracle announced a $300 billion, five-year deal in September to supply OpenAI with computing power. Two weeks later, the company raised $18 billion through bonds and notes. Then, just seven weeks ...

Oracle faces legal action from bondholders who claim the company withheld critical information when it raised nearly $20 billion in capital this September. The market is pricing Oracle bonds as ...

A growing number of companies are facing ransom demands from hackers who stole sensitive data through security flaws in widely-used Oracle business software nearly six months ago. The breach, which ...

Warren Buffett’s departure as CEO marks the end of an era at Berkshire Hathaway for the business 'sage' whose unpretentious approach reshaped modern investing. When the Oracle of Omaha speaks, ...

Here’s what could happen to Oracle shares next. Oracle stock dropped sharply after disappointing Q2 earnings and reports of data center delays. Analysts differ: Bank of America remains optimistic ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Oracle’s stock fell more than 12% on Thursday on growing fears about the software giant’s massive AI spending — shaving more than $30 billion off co-founder Larry Ellison’s fortune. The Texas-based ...

The cloud computing giant missed revenue expectations, as well as announcing an increase in its planned spending on AI data centres. Global markets failed to retain the momentum sparked by an interest ...

Quarterly revenue grew 14% year on year, but shares are down 11-12% following bad news The company is anticipating spending $15 billion more, largely due to AI Meta, Nvidia, and OpenAI are all major ...

Oracle's latest analyst consensus price target has edged down, moving from $344.04 to $342.28. This cautious revision comes amid evolving views on the company’s prospects, shaped by both bullish and ...